While your healthcare provider will go over the options best suited for you, heres how they break down: GLP-1 Receptor Agonist Drugs Semaglutide: Ozempic, Wegovy, Rybelsus Liraglutide: Victoza, Saxenda Dulaglutide: Trulicity Dual GIP/GLP-1 Receptor Agonists Tirzepatide: Mounjaro and Zepbound Ozempic and similar medications work on multiple fronts to help control blood sugar and produce weight loss
Dozens of peptide drugs are now FDAapproved (for example, some GLP1 receptor agonists for diabetes and obesity), and many more are being studied for tissue repair, immune support, and agerelated conditions
Mechanism of Action (Based on Research) GLP2-T acts as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, both of which are integral to the incretin system[1]
Do not double up doses to compensate
Having moderate to severe diabetic retinopathy before starting the medication A history of poorly controlled blood sugar over many years High blood pressure that is not well managed Kidney disease or other diabetes-related complications Very rapid reduction in hemoglobin A1C levels within the first few months Rare cases of sudden, painless vision loss from optic nerve injury have been reported in people using GLP-1 receptor agonists
Tips to manage common GLP-1 side effects: Follow the dose schedule and do not increase your dose without talking to your healthcare provider